Chen Shaotian, Jiang Xinyan, Li Xiang, Wang Tianyue, Yang Nan
Department of Pediatrics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, 110004, Liaoning Province, China.
Inflammation. 2025 Jul 24. doi: 10.1007/s10753-025-02338-w.
Ferroptosis is closely associated with the various pathological manifestations of asthma. This study aimed to explore the role of the stimulator of interferon genes (STING) in modulating airway inflammation in asthma, with a particular focus on regulating ferroptosis in airway epithelial cells. Using an ovalbumin (OVA)-sensitized mouse model of asthma, the OVA group exhibited significant inflammatory cell infiltration in the airways, increased mucus secretion, and elevated levels of inflammatory cytokines compared with those noted in the normal group. Additionally, the ferroptosis-related protein acyl-CoA synthetase long-chain family member 4 (ACSL4) was upregulated, whereas glutathione peroxidase 4 (GPX4) was downregulated, accompanied by elevated malondialdehyde (MDA) levels and reduced superoxide dismutase (SOD) activity. Furthermore, both messenger ribonucleic acid and protein levels of STING were significantly increased in the lungs of OVA-sensitized mice, with predominant expression in airway epithelial cells. After intervention with STING inhibitor C-176, the OVA + C-176 group demonstrated reduced inflammatory cell infiltration and mucus hypersecretion in the airways, along with decreased serum levels of IgE and Th2-associated cytokines (IL-4 and IL-13), but increased levels of the Th1 cytokine IFN-γ. Moreover, ACSL4 protein and MDA levels were significantly decreased, whereas SOD activity was significantly restored following C-176 intervention. Double immunofluorescence staining revealed the colocalization of STING and ACSL4, with their expression levels significantly reduced following C-176 treatment. Co-immunoprecipitation confirms the interaction between STING and ACSL4. Collectively, these findings indicate that STING regulates airway inflammation in asthma by modulating ferroptosis and lipid peroxidation, highlighting STING as a potential therapeutic target for asthma.
铁死亡与哮喘的各种病理表现密切相关。本研究旨在探讨干扰素基因刺激因子(STING)在调节哮喘气道炎症中的作用,特别关注其对气道上皮细胞铁死亡的调控。使用卵清蛋白(OVA)致敏的哮喘小鼠模型,与正常组相比,OVA组气道出现明显的炎性细胞浸润、黏液分泌增加以及炎性细胞因子水平升高。此外,铁死亡相关蛋白酰基辅酶A合成酶长链家族成员4(ACSL4)上调,而谷胱甘肽过氧化物酶4(GPX4)下调,同时丙二醛(MDA)水平升高,超氧化物歧化酶(SOD)活性降低。此外,OVA致敏小鼠肺组织中STING的信使核糖核酸和蛋白水平均显著升高,在气道上皮细胞中表达尤为明显。用STING抑制剂C-176干预后,OVA + C-176组气道炎性细胞浸润和黏液分泌过多减少,血清IgE水平以及Th2相关细胞因子(IL-4和IL-13)降低,但Th1细胞因子IFN-γ水平升高。此外,C-176干预后ACSL4蛋白和MDA水平显著降低,而SOD活性显著恢复。双重免疫荧光染色显示STING和ACSL4共定位,C-176处理后其表达水平显著降低。免疫共沉淀证实了STING与ACSL4之间的相互作用。这些研究结果共同表明,STING通过调节铁死亡和脂质过氧化来调控哮喘气道炎症,凸显了STING作为哮喘潜在治疗靶点的可能性。